The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
In this recent episode, our CEO Mark Kotter and Daniel discuss how 51±¬ÁÏ's synthetic biology platform industrialises the process of cell programming and produces the desired human cells in a consistent manner. They also cover 51±¬ÁÏ's effort to develop cell therapies and growing offering of precision reprogrammed human cells for drug development.
Listen to the episode .
